Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies
Frontiers in Medicine · 17.07.2026 · 13
DOI: 10.3389/fmed.2026.1865521 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Medicine, online erschienen am 17.07.2026. Verfasst von Xiaoli Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Yangpu District, Shanghai, China. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Considerable evidence suggests that hepatocellular carcinoma (HCC) is tightly related to metabolic disorders. However, it is not yet clear which metabolic risk factors play a critical role in hepatocarcinogenesis.
Methods
We searched Pubmed, Embase, and Web of Science from inception up to April 29, 2023. The hazard ratio (HR) and the corresponding 95% confidence interval (95%CI) were used to assess the pooled risk.
Results
Seventy-three studies involving more than 45 million participants were included. Among the metabolic risk factors: metabolic syndrome (MetS) (HR = 1.80, 95%CI: 1.44–2.25), diabetes mellitus (DM) (HR = 2.01, 95%CI: 1.79–2.27), body mass index (BMI) ≥ 24 kg/m 2 (HR = 1.47, 95%CI: 1.35–1.61), waist circumference (WC) (HR = 1.39, 95%CI: 1.26–1.55), waist-to-hip ratio (WHR) (HR = 1.33, 95%CI: 1.16–1.52), waist-to-height ratio (WHtR) (HR = 2.23, 95%CI: 1.42–3.51), reduced triglyceride (TG) (HR = 1.36, 95%CI: 1.09–1.69) and hypertension (HR = 1.43, 95%CI: 1.13–1.81) were positively associated with HCC risk. The disturbances of high-density lipoprotein cholesterol (HDL-C) levels (elevated, HR = 0.88, 95%CI: 0.81–0.96; reduced, HR = 0.96, 95%CI: 0.93–0.99) and elevated low-density lipoprotein cholesterol (LDL-C) (HR = 0.44, 95%CI: 0.32–0.62) were consistently associated with decreased risk of HCC. Nevertheless, elevated total cholesterol (TC) (HR = 0.87, 95%CI: 0.69–1.10) and elevated TG (HR = 0.72, 95%CI: 0.36–1.43) were not significantly associated with HCC risk.
Conclusion
Adverse metabolic risk factors are associated with an increased risk of HCC, which may provide new insights into HCC screening strategies for patients with these risk factors. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD42023401883 .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Yangpu District, Shanghai, China.
- Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Department of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Yang, X., Fu, P., & Liu, H. (2026). Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1865521
Vancouver
Yang X, Fu P, Liu H. Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1865521
BibTeX
@article{Yang2026,
author = {Yang, Xiaoli and Fu, Peng and Liu, Hui},
title = {Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1865521}
}
EUVIMED